LEONI, ALESSANDRO
 Distribuzione geografica
Continente #
NA - Nord America 1.603
AS - Asia 1.406
EU - Europa 1.072
SA - Sud America 193
Continente sconosciuto - Info sul continente non disponibili 50
AF - Africa 49
OC - Oceania 6
Totale 4.379
Nazione #
US - Stati Uniti d'America 1.528
IT - Italia 586
SG - Singapore 527
CN - Cina 278
BD - Bangladesh 182
BR - Brasile 151
HK - Hong Kong 134
DE - Germania 119
VN - Vietnam 90
FR - Francia 74
FI - Finlandia 52
GB - Regno Unito 50
IN - India 45
CA - Canada 37
RU - Federazione Russa 35
TR - Turchia 29
NL - Olanda 25
PL - Polonia 23
MX - Messico 22
CZ - Repubblica Ceca 21
ZA - Sudafrica 20
ES - Italia 19
JP - Giappone 16
TH - Thailandia 16
IQ - Iraq 12
AR - Argentina 11
IE - Irlanda 11
SE - Svezia 11
AT - Austria 9
CO - Colombia 9
EG - Egitto 9
ID - Indonesia 9
UA - Ucraina 9
CH - Svizzera 8
MA - Marocco 8
IR - Iran 7
AU - Australia 6
AE - Emirati Arabi Uniti 5
BE - Belgio 5
EC - Ecuador 5
OM - Oman 5
SA - Arabia Saudita 5
TW - Taiwan 5
DZ - Algeria 4
LK - Sri Lanka 4
MY - Malesia 4
NP - Nepal 4
PH - Filippine 4
VE - Venezuela 4
CL - Cile 3
CR - Costa Rica 3
ET - Etiopia 3
GR - Grecia 3
JM - Giamaica 3
KR - Corea 3
PE - Perù 3
PS - Palestinian Territory 3
PT - Portogallo 3
PY - Paraguay 3
UY - Uruguay 3
UZ - Uzbekistan 3
AL - Albania 2
AZ - Azerbaigian 2
IL - Israele 2
KE - Kenya 2
KG - Kirghizistan 2
KZ - Kazakistan 2
LB - Libano 2
LT - Lituania 2
PA - Panama 2
PK - Pakistan 2
SN - Senegal 2
AM - Armenia 1
AW - Aruba 1
BO - Bolivia 1
BZ - Belize 1
CY - Cipro 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
EE - Estonia 1
GT - Guatemala 1
JO - Giordania 1
NI - Nicaragua 1
PR - Porto Rico 1
RO - Romania 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
Totale 4.329
Città #
Singapore 316
San Jose 210
Ashburn 186
Hong Kong 133
New York 104
Brescia 82
Los Angeles 73
Council Bluffs 71
Milan 63
Munich 63
Dallas 62
Beijing 60
Columbus 42
The Dalles 42
Santa Clara 34
Rome 33
Des Moines 32
Lauterbourg 32
Helsinki 29
Chandler 27
Ho Chi Minh City 26
Boardman 25
Hanoi 24
São Paulo 21
Istanbul 20
Shanghai 20
Buffalo 18
Frankfurt am Main 18
San Francisco 18
Turku 17
Chicago 16
Seattle 16
Brno 15
Redondo Beach 15
Tokyo 15
Turin 15
Orem 14
Atlanta 13
Bangkok 13
London 13
Toronto 13
Warsaw 13
Barlassina 12
Johannesburg 12
Mexico City 12
Nuremberg 12
Boston 11
Dublin 10
Poplar 10
Verona 10
Wroclaw 10
Chennai 9
Romola 9
Stockholm 9
Brooklyn 8
Moscow 8
Bovegno 7
Charlotte 7
Modena 7
Mumbai 7
Phoenix 7
Zurich 7
Bologna 6
Denver 6
Fairfield 6
Florence 6
Houston 6
Manchester 6
Paris 6
Parma 6
Princeton 6
Baghdad 5
Cairo 5
Düsseldorf 5
Lappeenranta 5
Montreal 5
Newark 5
Olomouc 5
Palermo 5
Pune 5
Tianjin 5
Brussels 4
Colombo 4
Cremona 4
Da Nang 4
Hải Dương 4
Jakarta 4
Kolkata 4
Maple Grove 4
Minneapolis 4
Ottawa 4
Padua 4
Pescara 4
Pittsburgh 4
Poncarale 4
Sommacampagna 4
Sulaymaniyah 4
Addis Ababa 3
Ancona 3
Bari 3
Totale 2.433
Nome #
Feasibility Study on detection and monitoring of gene-mutations by digital (dPCR) NGS driven in patients with Acute Myeloid Leukemias (AMLs) and High-Risk Myelodysplastic Syndromes (HR-MDSs)- “dPCR-NGS Driven Study” 228
Evaluation of Circulating Endothelial Cells as Direct Marker of Endothelial Damage in Allo-Transplant Recipients at High Risk of Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome 192
Venetoclax plus decitabine as a bridge to allogeneic haematopoietic stem-cell transplantation in older patients with acute myeloid leukaemia (VEN-DEC GITMO): final report of a multicentre, single-arm, phase 2 trial 166
High risk-myelodysplastic syndrome following CAR T-cell therapy in a patient with relapsed diffuse large B cell lymphoma: A case report and literature review 162
Different In Vitro Models of Chronic Myeloid Leukemia Show Different Characteristics: Biological Replicates Are Not Biologically Equivalent 156
Is the New Tci Score Sufficient to Categorize the Intensity of Conditioning? a Single-Centre Study 150
Bone marrow CD34+ molecular chimerism as an early predictor of relapse after allogeneic stem cell transplantation in patients with acute myeloid leukemia 147
CT-290: Clinical Frailty Scale as a Novel Tool to Evaluate Patients’ Eligibility for Allogeneic Stem Cell Transplant: A Single-Center Experience on 234 Patients >50 Years Old 147
P1450: AUTOLOGOUS STEM CELL TRANSPLANTATION INDUCES HIGHER LEVEL OF EXHAUSTED T-CELLS IN DLBCL PATIENTS BEFORE LEUKAPHERESIS FOR CAR-T CELL THERAPY 134
PB2209: HIGH RISK MYELODYSPLASTIC SYNDROME DEVELOPING IN A PATIENT AFTER CHIMERIC ANTIGEN RECEPTOR (CAR) T- CELL THERAPY FOR RELAPSED DIFFUSE LARGE B CELL LYMPHOMA 132
Nutritional intervention with TGF-beta enriched food for special medical purposes (TGF-FSMP) is associated with a reduction of malnutrition, acute GVHD, pneumonia and may improve overall survival in patients undergoing allogeneic hematopoietic stem transplantation 130
Autologous Stem Cell Transplantation before Lymphocyte Apheresis for CAR-T Cells Therapy Negatively Impacts on T-Cells Fitness and NK Cell Levels in DLBCL Patients 129
Changes in Stem Cell Transplant activity and procedures during SARS-CoV2 pandemic in Italy: an Italian Bone Marrow Transplant Group (GITMO) nationwide analysis (TransCOVID-19 Survey) 125
Feasibility of Leukemia-Derived Exosome Enrichment and Co-isolated dsDNA Sequencing in Acute Myeloid Leukemia Patients: A Proof of Concept for New Leukemia Biomarkers Detection 124
Correlation between BCR::ABL1 Transcript LEVEL in Circulating Extracellular Vesicles and BOTH the Molecular Response and the Ongoing Therapy: A Study on Adult CML Patients 113
Timely Leukapheresis May Interfere with the “Fitness” of Lymphocytes Collected for CAR-T Treatment in High Risk DLBCL Patients 111
Potentiality of Bone Marrow-Derived Mesenchymal Stromal Cells (BM-MSCs) to Differentiate into the Osteogenic Lineage in in Vitro Model of Tissue Regeneration 110
Malnutrition Prevention after Allogeneic Hematopoietic Stem Cell Transplantation (alloHSCT): A Prospective Explorative Interventional Study with an Oral Polymeric Formulation Enriched with Transforming Growth Factor Beta 2 (TGF-β2) 108
Evaluation of Circulating Endothelial Cells (CECs) As Marker of Endothelial Damage in Allo-Transplanted Patients at High Risk of Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome (VOD/SOS): The Cecinvod Study 107
Secondary Myeloid Neoplasms after CD19 CAR-T Cell Therapy: Real-Life Multicenter Data from the Clonhema Study 106
The Applications of Machine Learning in the Management of Patients Undergoing Stem Cell Transplantation: Are We Ready? 103
Successful CAR-T cell therapy in a refractory MCL patient with bacterial, fungal and COVID-19 infection: a case report 103
Immune Reconstitution after Allogenic Stem Cell Transplantation in Patients with Myelofibrosis 103
CMV prophylaxis with letermovir significantly improves graft and relapse free survival following allogeneic stem cell transplantation 100
PB1959: BCR::ABL1 TRANSCRIPT IN SMALL EXTRACELLULAR VESICLES ISOLATED IN ADULT CHRONIC MYELOID LEUKEMIA PATIENTS CORRELATES WITH MOLECULAR RESPONSE LEVEL AND THE ONGOING THERAPY 100
How We Manage Myelofibrosis Candidates for Allogeneic Stem Cell Transplantation 97
Donor Lymphocyte Infusion in the Treatment of Post-Transplant Relapse of Acute Myeloid Leukemias and Myelodysplastic Syndromes Significantly Improves Overall Survival: A French–Italian Experience of 134 Patients 96
Assessment of Chronic Myeloid Leukaemia In Vitro Models Variability: Insights Into Extracellular Vesicles 85
Real-world outcomes of total body irradiation-based conditioning in allogeneic hematopoietic stem cell transplantation: A single-center retrospective study 83
Digital PCR (dPCR) is able to anticipate the achievement of stable deep molecular response in adult chronic myeloid leukemia patients: results of the DEMONSTRATE study 83
Correction: CMV prophylaxis with letermovir significantly improves graft and relapse free survival following allogeneic stem cell transplantation (Bone Marrow Transplantation, (2023), 10.1038/s41409-023-02124-y) 80
Isolated Cerebral Myeloid Sarcoma in an Allogeneic Stem Cell Transplant Recipient 77
Real-world collection of secondary myeloid neoplasms after CD19 CAR-T cell therapy: first report of the ClonHema study 63
Stimulated CAR-T cells from non-Hodgkin lymphomas patients engage and activate monocytes via extracellular vesicles 42
Beyond presence: Clinical relevance of FLT3-ITD length and location in Acute Myeloid Leukemia (AML) 40
Tracking leukemic residuals: dissecting the inverse relationship between CD26+ stem cells and extracellular BCR::ABL1 transcript in Chronic Myeloid Leukemia (CML) 38
P022 | Fourier-transform infrared spectroscopy analysis of plasma-derived extracellular vesicles as a tool to detect TKI-related toxicity in chronic myeloid leukemia patients: a preliminary study 38
P046 | Beyond the mutation: prognostic role of FLT3-ITD length and genomic context in acute myeloid leukemia 37
Psychosocial well-being in patients undergoing allogeneic hematopoietic stem cell transplantation (allo-HSCT) and their caregivers: A prospective study 37
CO41 | Monocyte activation by CAR-T cells: role of extracellular vesicles and secretome in immune modulation 37
P044 | From cells to vesicles: next-generation measurable residual disease tracking in acute myeloid leukemia with NGS and digital PCR 32
CO43 | Fourier-transform infrared spectroscopy of plasma as a liquid biopsy for monitoring acute myeloid leukemia and extramedullary relapse following allo-HSCT 29
Transcriptomic analysis of CD34⁺ cells in myelofibrosis highlights their role in extracellular matrix dysregulation and marrow fibrosis 28
A phase II multicenter prospective study to evaluate the safety and efficacy of myeloablative-dose treosulfan plus fludarabine (FT14) conditioning regimen in allogeneic hematopoietic stem cell transplantation for AML patients aged 40-65 in first complete remission 20
P026 | Tracking residual chronic myeloid leukemia: complementary insights from CD26⁺ stem cells and extracellular BCR::ABL1 19
CO61 | Transcriptomic analysis of CD34⁺ cells in myelofibrosis highlights their role in extracellular matrix dysregulation and marrow fibrosis 19
NGS-Driven Digital PCR for Personalized and Accurate Measurable Residual Disease Assessment in Acute Myeloid Leukemia 13
Totale 4.379
Categoria #
all - tutte 19.281
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.281


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202241 0 0 2 0 0 0 5 10 3 9 3 9
2022/2023132 4 1 8 23 8 26 0 12 14 4 16 16
2023/2024284 5 7 16 16 28 49 17 17 39 10 8 72
2024/2025932 8 28 25 72 57 61 72 44 164 105 166 130
2025/20262.670 138 176 150 281 251 241 364 130 224 269 203 243
2026/2027313 195 118 0 0 0 0 0 0 0 0 0 0
Totale 4.379